Fentanyl vs Dexmedetomidine with intrathecal levobupivacaine in elective cesarean section

Intrathecal Fentanyl versus Intrathecal Dexmedetomidine as an adjuvant to Isobaric Levobupivacaine in Cesarean section in a Tertiary care center in Chengalpet district-Randomised control trial

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2021/09/036511

Enrollment

Registered

2021-09-15

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical

Interventions

Intervention1: FENTANYL AS AN ADJUVANT TO ISOBARIC LEVOBUPIVACAINE: GROUP LF WILL RECEIVE 2ML OF 0.5% LEVOBUPIVACAINE WITH FENTANYL 25MCG INTRATHECALLY .PATIENTS WILL BE MONITORED INTRAOPERATIVELY

Eligibility

Inclusion criteria

Inclusion criteria: WOMEN WITH FULL TERM PREGNANCIES WOMEN BELONGING TO ASA 1 AND 2 POSTED FOR ELECTIVE CESAREAN SECTION AGE GROUP 18-35 YEARS

Exclusion criteria

Exclusion criteria: EMERGENCY CESAREAN SECTION MATERNAL MEDICAL CO-MORBIDITIES INFECTION AT NEEDLE SITE REFUSAL TO SPINAL ANAESTHESIA ALLERGIC TO LOCAL ANAESTHETICS AND ADJUVANTS

Design outcomes

Primary

Measure	Time frame
TO COMPARE THE DURATION OF POST OPERATIVE ANALGESIA OF LEVOBUPIVACAINE WITH FENTANYL VERSUS LEVOBUPIVACAINE WITH DEXMEDETOMIDINETimepoint: 18 MONTHS	—

Secondary

Measure	Time frame
To compare the intraoprative haemodynamic changes, level pf motor ad sensory blockade between the two groupsTimepoint: 18 MONTHS	—

Countries

India

Contacts

Public ContactMOHAMED BASITH

Shri sathya sai medical college and research institute.

dilipko@gmail.com909490243

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026